The Neuronal Transporter Gene SLC6A15 Confers Risk to Major Depression

Neuron

Volumn 70, Issue 2, 2011, Pages 252-265

  Kohli, Martin A ^a   Lucae, Susanne ^a   Saemann, Philipp G ^a   Schmidt, Mathias V ^a   Demirkan, Ayse ^b   Hek, Karin ^b   Czamara, Darina ^a   Alexander, Michael ^c   Salyakina, Daria ^a   Ripke, Stephan ^a   Hoehn, David ^a   Specht, Michael ^a   Menke, Andreas ^a   Hennings, Johannes ^a   Heck, Angela ^a   Wolf, Christiane ^a   Ising, Marcus ^a   Schreiber, Stefan ^d   Czisch, Michael ^a   Müller, Marianne B ^a   Uhr, Manfred ^a   Bettecken, Thomas ^a   Becker, Albert ^e   Schramm, Johannes ^e   Rietschel, Marcella ^f   Maier, Wolfgang ^c   Bradley, Bekh ^g,h   Ressler, Kerry J ^g,i,j   Nöthen, Markus M ^c   Cichon, Sven ^c,k   Craig, Ian W ^l   Breen, Gerome ^l   Lewis, Cathryn M ^l   Hofman, Albert ^b   Tiemeier, Henning ^b   van Duijn, Cornelia M ^b   Holsboer, Florian ^a   Müller Myhsok, Bertram ^a   Binder, Elisabeth B ^a,g   more..

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF BONN   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

^e UNIVERSITY HOSPITAL BONN   (Germany)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h HOWARD HUGHES MEDICAL INSTITUTE   (United States)

ⁱ EMORY UNIVERSITY   (United States)

^j ATLANTA VA MEDICAL CENTER   (United States)

^k FORSCHUNGSZENTRUM JÜLICH   (Germany)

^l KING'S COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRAL AMINO ACID TRANSPORTER; PROTEIN; SLC6A15 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ALLELE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SIZE; CHRONIC STRESS; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; ENVIRONMENTAL FACTOR; FEMALE; GENE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HEREDITY; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MOUSE; NEUROIMAGING; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; PRODUCTIVITY; SLC6A15 GENE;

ADULT; AMINO ACID TRANSPORT SYSTEMS, NEUTRAL; ANALYSIS OF VARIANCE; ANIMALS; ASPARTIC ACID; CHROMOSOMES, HUMAN, PAIR 12; DEPRESSIVE DISORDER, MAJOR; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GERMANY; GREAT BRITAIN; HIPPOCAMPUS; HUMANS; LINKAGE DISEQUILIBRIUM; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; META-ANALYSIS AS TOPIC; MICE; MIDDLE AGED; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; RNA, MESSENGER; STRESS, PSYCHOLOGICAL; TRITIUM;

EID: 79955088880     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2011.04.005     Document Type: Article

References (70)

1. Allen Brain Atlas. (2008). (Seattle, WA: Allen Institute for Brain Science). Available from http://www.brain-map.org.
2. Alexopoulos G.S. The vascular depression hypothesis: 10 years later. Biol. Psychiatry 2006, 60:1304-1305.
3. Amunts K., Kedo O., Kindler M., Pieperhoff P., Mohlberg H., Shah N.J., Habel U., Schneider F., Zilles K. Cytoarchitectonic mapping of the human amygdala, hippocampal region and entorhinal cortex: Intersubject variability and probability maps. Anat. Embryol. (Berl.) 2005, 210:343-352.
4. Aulchenko Y.S., Heutink P., Mackay I., Bertoli-Avella A.M., Pullen J., Vaessen N., Rademaker T.A., Sandkuijl L.A., Cardon L., Oostra B., van Duijn C.M. Linkage disequilibrium in young genetically isolated Dutch population. Eur. J. Hum. Genet. 2004, 12:527-534.
5. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
6. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961, 4:561-571.
7. Benarroch E.E. N-acetylaspartate and N-acetylaspartylglutamate: Neurobiology and clinical significance. Neurology 2008, 70:1353-1357.
8. Binder E.B., Bradley R.G., Liu W., Epstein M.P., Deveau T.C., Mercer K.B., Tang Y., Gillespie C.F., Heim C.M., Nemeroff C.B., et al. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. JAMA 2008, 299:1291-1305.
9. Birney E., Stamatoyannopoulos J.A., Dutta A., Guigó R., Gingeras T.R., Margulies E.H., Weng Z.P., Snyder M., Dermitzakis E.T., Thurman R.E., et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007, 447:799-816. ENCODE Project Consortium, NISC Comparative Sequencing ProgramNISC Comparative Sequencing Program, Baylor College of Medicine Human Genome Sequencing CenterBaylor College of Medicine Human Genome Sequencing Center, Washington University Genome Sequencing CenterWashington University Genome Sequencing Center, Broad InstituteBroad Institute, Children's Hospital Oakland Research InstituteChildren's Hospital Oakland Research Institute.
10. Bostwick J.M., Pankratz V.S. Affective disorders and suicide risk: A reexamination. Am. J. Psychiatry 2000, 157:1925-1932.
11. Bröer S. The SLC6 orphans are forming a family of amino acid transporters. Neurochem. Int. 2006, 48:559-567.
12. Bröer A., Tietze N., Kowalczuk S., Chubb S., Munzinger M., Bak L.K., Bröer S. The orphan transporter v7-3 (slc6a15) is a Na+-dependent neutral amino acid transporter (B0AT2). Biochem. J. 2006, 393:421-430.
13. Browning B.L., Browning S.R. A unified approach to genotype imputation and haplotype-phase inference for large data sets of trios and unrelated individuals. Am. J. Hum. Genet. 2009, 84:210-223.
14. Choy W.C., López-León S., Aulchenko Y.S., Mackenbach J.P., Oostra B.A., van Duijn C.M., Janssens A.C. Role of shared genetic and environmental factors in symptoms of depression and body composition. Psychiatr. Genet. 2009, 19:32-38.
15. Czéh B., Michaelis T., Watanabe T., Frahm J., de Biurrun G., van Kampen M., Bartolomucci A., Fuchs E. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc. Natl. Acad. Sci. USA 2001, 98:12796-12801.
16. Devlin B., Roeder K., Wasserman L. Genomic control, a new approach to genetic-based association studies. Theor. Popul. Biol. 2001, 60:155-166.
17. Drgonova J., Liu Q.R., Hall F.S., Krieger R.M., Uhl G.R. Deletion of v7-3 (SLC6A15) transporter allows assessment of its roles in synaptosomal proline uptake, leucine uptake and behaviors. Brain Res. 2007, 1183:10-20.
18. Dudbridge F., Gusnanto A. Estimation of significance thresholds for genomewide association scans. Genet. Epidemiol. 2008, 32:227-234.
19. Easton D.F., Pooley K.A., Dunning A.M., Pharoah P.D., Thompson D., Ballinger D.G., Struewing J.P., Morrison J., Field H., Luben R., et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007, 447:1087-1093. SEARCH collaborators, kConFabkConFab, AOCS Management GroupAOCS Management Group.
20. Ebmeier K.P., Donaghey C., Steele J.D. Recent developments and current controversies in depression. Lancet 2006, 367:153-167.
21. Farmer M.K., Robbins M.J., Medhurst A.D., Campbell D.A., Ellington K., Duckworth M., Brown A.M., Middlemiss D.N., Price G.W., Pangalos M.N. Cloning and characterization of human NTT5 and v7-3: Two orphan transporters of the Na+/Cl- -dependent neurotransmitter transporter gene family. Genomics 2000, 70:241-252.
22. Fava M., Rush A.J. Current status of augmentation and combination treatments for major depressive disorder: A literature review and a proposal for a novel approach to improve practice. Psychother. Psychosom. 2006, 75:139-153.
23. Frazer K.A., Ballinger D.G., Cox D.R., Hinds D.A., Stuve L.L., Gibbs R.A., Belmont J.W., Boudreau A., Hardenbol P., Leal S.M., et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 2007, 449:851-861. International HapMap Consortium.
24. Frodl T., Meisenzahl E.M., Zetzsche T., Born C., Groll C., Jäger M., Leinsinger G., Bottlender R., Hahn K., Möller H.J. Hippocampal changes in patients with a first episode of major depression. Am. J. Psychiatry 2002, 159:1112-1118.
25. Gabriel S.B., Schaffner S.F., Nguyen H., Moore J.M., Roy J., Blumenstiel B., Higgins J., DeFelice M., Lochner A., Faggart M., et al. The structure of haplotype blocks in the human genome. Science 2002, 296:2225-2229.
26. Glahn D.C., Thompson P.M., Blangero J. Neuroimaging endophenotypes: Strategies for finding genes influencing brain structure and function. Hum. Brain Mapp. 2007, 28:488-501.
27. Heck A., Lieb R., Ellgas A., Pfister H., Lucae S., Erhardt A., Himmerich H., Horstmann S., Kloiber S., Ripke S., et al. Polymorphisms in the angiotensin-converting enzyme gene region predict coping styles in healthy adults and depressed patients. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 2009, 150B:104-114.
28. Heinzen E.L., Ge D., Cronin K.D., Maia J.M., Shianna K.V., Gabriel W.N., Welsh-Bohmer K.A., Hulette C.M., Denny T.N., Goldstein D.B. Tissue-specific genetic control of splicing: Implications for the study of complex traits. PLoS Biol. 2008, 6:e1.
29. Hennings J.M., Owashi T., Binder E.B., Horstmann S., Menke A., Kloiber S., Dose T., Wollweber B., Spieler D., Messer T., et al. Clinical characteristics and treatment outcome in a representative sample of depressed inpatients - findings from the Munich Antidepressant Response Signature (MARS) project. J. Psychiatr. Res. 2009, 43:215-229.
30. Herman J.P., Figueiredo H., Mueller N.K., Ulrich-Lai Y., Ostrander M.M., Choi D.C., Cullinan W.E. Central mechanisms of stress integration: Hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front. Neuroendocrinol. 2003, 24:151-180.
31. Hofman A., Breteler M.M., van Duijn C.M., Krestin G.P., Pols H.A., Stricker B.H., Tiemeier H., Uitterlinden A.G., Vingerling J.R., Witteman J.C. The Rotterdam Study: Objectives and design update. Eur. J. Epidemiol. 2007, 22:819-829.
32. Ising M., Lucae S., Binder E.B., Bettecken T., Uhr M., Ripke S., Kohli M.A., Hennings J.M., Horstmann S., Kloiber S., et al. A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression. Arch. Gen. Psychiatry 2009, 66:966-975.
33. Kendler K.S., Gardner C.O., Prescott C.A. Toward a comprehensive developmental model for major depression in women. Am. J. Psychiatry 2002, 159:1133-1145.
34. Kessler R.C., Berglund P., Demler O., Jin R., Koretz D., Merikangas K.R., Rush A.J., Walters E.E., Wang P.S. The epidemiology of major depressive disorder: Results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003, 289:3095-3105. National Comorbidity Survey Replication.
35. Kleinjan D.A., van Heyningen V. Long-range control of gene expression: Emerging mechanisms and disruption in disease. Am. J. Hum. Genet. 2005, 76:8-32.
36. Levinson D.F. The genetics of depression: A review. Biol. Psychiatry 2006, 60:84-92.
37. Lewis C.M., Ng M.Y., Butler A.W., Cohen-Woods S., Uher R., Pirlo K., Weale M.E., Schosser A., Paredes U.M., Rivera M., et al. Genome-wide association study of major recurrent depression in the U.K. population. Am. J. Psychiatry 2010, 167:949-957.
38. Li C.X., Wang Y., Gao H., Pan W.J., Xiang Y., Huang M., Lei H. Cerebral metabolic changes in a depression-like rat model of chronic forced swimming studied by ex vivo high resolution 1H magnetic resonance spectroscopy. Neurochem. Res. 2008, 33:2342-2349.
39. Lucae S., Salyakina D., Barden N., Harvey M., Gagné B., Labbé M., Binder E.B., Uhr M., Paez-Pereda M., Sillaber I., et al. P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder. Hum. Mol. Genet. 2006, 15:2438-2445.
40. Luijendijk H.J., van den Berg J.F., Dekker M.J., van Tuijl H.R., Otte W., Smit F., Hofman A., Stricker B.H., Tiemeier H. Incidence and recurrence of late-life depression. Arch. Gen. Psychiatry 2008, 65:1394-1401.
41. Masson J., Pohl M., Aïdouni Z., Giros B., Hamon M., el Mestikawy S. The two orphan Na+/Cl(-)-dependent transporters Rxt1 and V-7-3-2 have an overlapping expression pattern in the rat central nervous system. Receptors Channels 1996, 4:227-242.
42. Muglia P., Tozzi F., Galwey N.W., Francks C., Upmanyu R., Kong X.Q., Antoniades A., Domenici E., Perry J., Rothen S., et al. Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts. Mol. Psychiatry 2010, 15:589-601.
43. Myers S., Bottolo L., Freeman C., McVean G., Donnelly P. A fine-scale map of recombination rates and hotspots across the human genome. Science 2005, 310:321-324.
44. Myers A.J., Gibbs J.R., Webster J.A., Rohrer K., Zhao A., Marlowe L., Kaleem M., Leung D., Bryden L., Nath P., et al. A survey of genetic human cortical gene expression. Nat. Genet. 2007, 39:1494-1499.
45. Price A.L., Patterson N.J., Plenge R.M., Weinblatt M.E., Shadick N.A., Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 2006, 38:904-909.
46. Pruitt K.D., Tatusova T., Maglott D.R. NCBI Reference Sequence (RefSeq): A curated non-redundant sequence database of genomes, transcripts and proteins. Nucleic Acids Res. 2005, 33:501-504.
47. Purcell S., Cherny S.S., Sham P.C. Genetic Power Calculator: Design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003, 19:149-150.
48. Radloff L.S. The CES-D Scale: A self-report depression scale for research in the general population. Appl. Psychol. Meas. 1977, 3:385.
49. Rietschel M., Mattheisen M., Frank J., Treutlein J., Degenhardt F., Breuer R., Steffens M., Mier D., Esslinger C., Walter H., et al. Genome-wide association-, replication-, and neuroimaging study implicates HOMER1 in the etiology of major depression. Biol. Psychiatry 2010, 68:578-585.
50. Schmidt M.V., Sterlemann V., Ganea K., Liebl C., Alam S., Harbich D., Greetfeld M., Uhr M., Holsboer F., Müller M.B. Persistent neuroendocrine and behavioral effects of a novel, etiologically relevant mouse paradigm for chronic social stress during adolescence. Psychoneuroendocrinology 2007, 32:417-429.
51. Schmidt M.V., Scharf S.H., Sterlemann V., Ganea K., Liebl C., Holsboer F., Müller M.B. High susceptibility to chronic social stress is associated with a depression-like phenotype. Psychoneuroendocrinology 2010, 35:635-643.
52. Shi J., Potash J.B., Knowles J.A., Weissman M.M., Coryell W., Scheftner W.A., Lawson W.B., DePaulo J.R., Gejman P.V., Sanders A.R., et al. Genome-wide association study of recurrent early-onset major depressive disorder. Mol. Psychiatry 2011, 16:193-201.
53. Spinhoven P., Ormel J., Sloekers P.P., Kempen G.I., Speckens A.E., Van Hemert A.M. A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. Psychol. Med. 1997, 27:363-370.
54. Sterlemann V., Ganea K., Liebl C., Harbich D., Alam S., Holsboer F., Müller M.B., Schmidt M.V. Long-term behavioral and neuroendocrine alterations following chronic social stress in mice: Implications for stress-related disorders. Horm. Behav. 2008, 53:386-394.
55. Stranger B.E., Forrest M.S., Clark A.G., Minichiello M.J., Deutsch S., Lyle R., Hunt S., Kahl B., Antonarakis S.E., Tavaré S., et al. Genome-wide associations of gene expression variation in humans. PLoS Genet. 2005, 1:e78.
56. Stranger B.E., Nica A.C., Forrest M.S., Dimas A., Bird C.P., Beazley C., Ingle C.E., Dunning M., Flicek P., Koller D., et al. Population genomics of human gene expression. Nat. Genet. 2007, 39:1217-1224.
57. Sullivan E.V., Pfefferbaum A., Swan G.E., Carmelli D. Heritability of hippocampal size in elderly twin men: Equivalent influence from genes and environment. Hippocampus 2001, 11:754-762.
58. Sullivan P.F., de Geus E.J., Willemsen G., James M.R., Smit J.H., Zandbelt T., Arolt V., Baune B.T., Blackwood D., Cichon S., et al. Genome-wide association for major depressive disorder: A possible role for the presynaptic protein piccolo. Mol. Psychiatry 2009, 14:359-375.
59. Tapiero H., Mathé G., Couvreur P., Tew K.D. II. Glutamine and glutamate. Biomed. Pharmacother. 2002, 56:446-457.
60. UniGene. (2009). http://www.ncbi.nlm.nih.gov/sites/entrez?db=unigene.
61. Ustün T.B., Ayuso-Mateos J.L., Chatterji S., Mathers C., Murray C.J.L. Global burden of depressive disorders in the year 2000. Br. J. Psychiatry 2004, 184:386-392.
62. Videbech P., Ravnkilde B. Hippocampal volume and depression: A meta-analysis of MRI studies. Am. J. Psychiatry 2004, 161:1957-1966.
63. Viinamäki H., Tanskanen A., Honkalampi K., Koivumaa-Honkanen H., Haatainen K., Kaustio O., Hintikka J. Is the Beck Depression Inventory suitable for screening major depression in different phases of the disease?. Nord. J. Psychiatry 2004, 58:49-53.
64. Wang J.L. Work stress as a risk factor for major depressive episode(s). Psychol. Med. 2005, 35:865-871.
65. Weissman M.M., Sholomskas D., Pottenger M., Prusoff B.A., Locke B.Z. Assessing depressive symptoms in five psychiatric populations: A validation study. Am. J. Epidemiol. 1977, 106:203-214.
66. Westfall P.H., Young S.S. Resampling-Based Multiple Testing 1993, John Wiley & Sons, Inc., New York.
67. Westfall P.H., Zaykin D.V., Young S.S. Multiple Tests for Genetics Effects in Association Studies: Biostatistical Methods 2001, Humana Press, Totawa, NJ.
68. Wray N.R., Pergadia M.L., Blackwood D.H., Penninx B.W., Gordon S.D., Nyholt D.R., Ripke S., Macintyre D.J., McGhee K.A., Maclean A.W., et al. Genome-wide association study of major depressive disorder: new results, meta-analysis, and lessons learned. Mol. Psychiatry 2010, in press. Published online November 2, 2010. 10.1038/mp.2010.109.
69. Zhou Z., Zhen J., Karpowich N.K., Goetz R.M., Law C.J., Reith M.E.A., Wang D.N. LeuT-desipramine structure reveals how antidepressants block neurotransmitter reuptake. Science 2007, 317:1390-1393.
70. Zigmond A.S., Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr. Scand. 1983, 67:361-370.